Dr. Bryant Yenfong Lin, MD

Dr. Lin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lin's NPI, 1104908193, was assigned on October 19, 2006. Dr. Lin graduated from Tufts University School Of Medicine in 2002. Dr. Lin holds California license A95766.

Dr. Lin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Lin is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Lin to 1 more hospital, named with a free account. Dr. Lin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lin is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lin's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acid reflux, acute skin infection, arthritis, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Lin treats.

CMS data shows 492 Medicare services from Dr. Lin across 3 procedure codes in 2024, for 285 Medicare patients. Medicare paid $29,241 for them.

CMS counts 285 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 67, with 40% women.

In 2024, Dr. Lin wrote 3,661 Medicare Part D claims for 319 patients. 85% of them were for generic drugs. CMS names the drug for 2,907 of them, across 68 drugs with 11 or more claims each, at $296,019 in total drug cost. In 2023, CMS named 3,249 claims across 81 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 22 papers to Dr. Lin, published from 2017 to 2024. 2023 was the busiest year, with 6. The most frequent topics are Anticoagulants, Atrial Fibrillation and Stroke. Dr. Lin has published most often in J Am Heart Assoc. Dr. Lin's most frequent co-authors are Latha P. Palaniappan, MD, Paul Johnson Wang, MD and Krishna N. Pundi.

Dmand AI links Dr. Lin to 1 clinical trial. Conditions studied include Metabolic Syndrome and Non-alcoholic Fatty Liver Disease.

CMS Open Payments shows 9 general payments to Dr. Lin from 1 drug or device company in 2017. Speaker and faculty fees make up the largest share, 96% of the total. Arrinex, Inc. paid the most, $27,128.

Dr. Lin graduated from Tufts University School Of Medicine in 2002.

Dr. Lin is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.